Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2008 Results
Date:2/18/2009

$68,649 Preferred stock dividends $- $- Net (loss) income available to common stockholders - basic $(244,753) $68,649 Net (loss) income per common share: Basic $(4.75) $1.33 Diluted $(4.75)(k) $1.27(m) Weighted average common shares - basic 51,510 51,510 Weighted average common shares - diluted 51,510(k) 54,236(m) (a) In calculating net income or loss on an adjusted cash basis, the Company excludes from net income or loss (i) certain non-cash charges, including amortization expense and stock-based compensation expense, (ii) non-recurring charges and income, and (iii) certain other charges and income that have a significant positive or negative impact on results yet do not occur on a consistent or regular basis in its business. In determining whether a particular item meets one of these criteria, management considers facts and circumstances that it believes are relevant. Management believes that excluding such charges and income from income or loss allows investors and management to evaluate and compare the Company's operating results from continuing operations from period to period in a meaningful and consistent manner. Due to the frequency of their occurrence in its business, the Company does not adjust net income or loss for the costs associated with litigation, including payments made or received through settlements. It should be noted that "net income or loss on an adjusted cash basis" is not a standard financial measurement under
'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
2. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
3. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
4. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
5. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
6. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
7. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
8. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
9. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
10. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
11. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of ... for the second year to the Adams County Fairgrounds in Mendon, IL on May ... raise money to support music education in the underfunded school districts of Mendon and ...
(Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor ... Aneurysm Foundation has added yet another accolade to its cadre of widespread support—an official ... , “With the help of the medical community and the University of Illinois at ...
(Date:8/28/2015)... ... ... “ Frequentz ” was featured on NewsWatch as part of its monthly ... for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, ... track product movement from beginning to end. , Businesses benefit greatly from having the ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville Business Journal recently ... in business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is ... 2015 Veterans Awards will recognize Nashville military veterans who, through their professional and ...
(Date:8/28/2015)... Rochester, NY (PRWEB) , ... August 28, 2015 , ... ... injectable, Kybella™. It is the first and only nonsurgical product approved by the ... Dr. Vito Quatela and Dr. William Koenig are among ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... CEPH ) announced today that the underwriters ... aggregate principal amount of 2.50% convertible senior subordinated notes ... to purchase $65 million of additional notes, bringing the ... $500 million. Completion of the notes offering, including the ...
... Ontario Systems, a leading provider of revenue cycle ... management and health care industries, today announced that ... the company and will lead its debt management ... direction of all Ontario debt management solutions, including ...
... tied to this nutritional deficit , , FRIDAY, May ... may contribute to cancer development, U.S. researchers have found. ... communication among cells due to, among other things, low ... an epidemiologist at the Moores Cancer Center at the ...
... findings could alter treatment methods, , , THURSDAY, May 21 (HealthDay ... amputated because of diabetes were reduced by 36 percent when ... to lower their blood fat levels, new research has found. ... who took either 200 milligrams of fenofibrate or a placebo ...
... Patients under 44 were three times more likely to die, ... Younger men diagnosed with advanced prostate cancer don,t live as ... study finds. , "Overall, young men with prostate cancer do ... prostate cancers did substantially worse than old men with similar ...
... May 22 The National Board of Certification for ... performance exam that will be part of the testing ... weeks, 300 interpreters will "test the test" designed to ... and skills in real-life medical interpreting scenarios. This process ...
Cached Medicine News:Health News:Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes 2Health News:Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes 3Health News:Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes 4Health News:Cutler to Direct Debt Management Product Strategy at Ontario Systems 2Health News:Drug May Lessen Amputation Risk for Diabetics 2Health News:Advanced Prostate Cancer Deadlier in Younger Men 2Health News:Advanced Prostate Cancer Deadlier in Younger Men 3Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 2Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 3
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final ... (CDC) Contact Lens Health Week, 1-800 Contacts is sharing ... found that contact lens wearers who do not properly ... risk for eye infections. Most contact ... lenses, but a clean lens case is sometimes overlooked.  ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Ranibizumab Market, ... by Novartis, ranibizumab was approved by CFDA to treat ... only Lucentis, a product of Novartis, is available in ... first self- developed drug for the treatment of wet ...
(Date:8/28/2015)... , FARUM, Denmark and ... On July 31, 2015 the US Food and Drug Administration ... of Major Depressive Disorder in adult patients who have failed ... current episode. TMS is a non-invasive technique for stimulating neural ... suffering from Major Depressive Disorder. The procedure has been proven ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... March 16, 2011 Unilife Corporation ("Unilife" or the "Company") ... its Chief Executive Officer, Alan Shortall, has made open market ... the Australian Stock Exchange (ASX). Mr. Shortall, who ... 632,713 CDIs at an average price of A$0.795 (US$0.80) per ...
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... CMED ), a leading ... company, today announced that it ... following investor conferences and events: ...
Cached Medicine Technology:Unilife CEO Makes Open Market Purchase of A$500,000 in Company's Publicly Traded Shares 2Unilife CEO Makes Open Market Purchase of A$500,000 in Company's Publicly Traded Shares 3China Medical Technologies to Meet Investors 2
Desmarres Lid Retractor thin solid blades. Size 2....
... of the AMO Prestige System marked ... The combination of safety with high-performance ... of fluidic conditions in the in ... Pump" orchestrates the reaction and interaction ...
Highly versatile, efficient, compact and accurate digital readout display....
... phaco system has all the features of ... dependable engineering means minimal maintenance. Small, light ... site to site. Lowest cost reusable tubing ... No longer is there a price objection ...
Medicine Products: